Information Journal Paper
APA:
Copy. (2020). Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial. CIRCULATION, 141(2), 0-0. SID. https://sid.ir/paper/1003217/en
Vancouver:
Copy. Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial. CIRCULATION[Internet]. 2020;141(2):0-0. Available from: https://sid.ir/paper/1003217/en
IEEE:
Copy, “Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial,” CIRCULATION, vol. 141, no. 2, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/1003217/en